ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1577

Comparison Of Clinical and Serological Manifestations Among Juvenile-, Adult-, and Late-Onset Systemic Lupus Erythematosus Patients In Korea

Dong-Jin Park1, Ji-Hyoun Kang2, Kyung-Eun Lee1, Jeong-Won Lee2, Lihui Wen1, Tae-Jong Kim3, Yong-Wook Park1 and Shin-Seok Lee4, 1Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 2Chonnam National University Medical School, Gwangju, South Korea, 3Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, 4Dept of Int Med/Rheumatology, Chonnam National University Medical School, Gwangju, South Korea

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects II: Central Nervous System Manifestations, Therapeutics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Up to 30‑40% of patients with systemic lupus erythematosus (SLE) experience their onset prior to adulthood or at over 50 years of age. Patients with juvenile-onset SLE (JSLE) frequently present with severe organ involvement and higher disease activity at the onset of disease. In contrast, patients with late-onset SLE (LSLE) tend to show more insidious onset and mild initial clinical manifestations. However, few studies have investigated differences in clinical manifestations with disease onset in Asian lupus patients. Thus, we investigated whether SLE patients could be distinguished based on the time of disease onset and, if so, whether the groups differed in their clinical and laboratory features in ethnically homogeneous Korean patients.

Methods: We enrolled 201 SLE patients (mean age 34.1±12.7, 184 women) with available clinical data at the time of onset of SLE from the lupus cohort at Chonnam National University Hospital. Sociodemographic, clinical, and laboratory data, including autoantibodies, and concomitant diseases were found at the time of diagnosis of SLE by reviewing the patient charts. We divided SLE patients according to age at SLE diagnosis into three groups: JSLE (diagnosed at ≤ 18 years), adult-onset SLE (ASLE, diagnosed at 19-50 years), and LSLE (diagnosed at > 50 years), and compared baseline demographic, clinical, and relevant laboratory findings. Data were analyzed using the chi-squared test for categorical variables and one-way ANOVA test for continuous variables.

Results: Of the 210 patients, 27 (14.4%), 149 (74.1 %), and 25 (12.4 %) were JSLE, ASLE, and LSLE patients, respectively. Fever, oral ulcer, nephritis, anemia, and thrombocytopenia were more common in JSLE patients than ASLE or LSLE patients (p < 0.05, p < 0.05, p = 0.001, p < 0.05, and p < 0.05, respectively). On the other hand, Sjögren’s syndrome was found more frequently in LSLE patients than JSLE or ASLE patients (p < 0.05). SLEDAI-2000 scores at the onset of SLE were 14.6±7.1 in JSLE, 11.1±6.1 in ASLE, and 6.6±2.7 in LSLE, and disease activity was significantly higher in JSLE patients than in ASLE or LSLE patients (p < 0.001). Anti-dsDNA and anti-nucleosome antibodies were found more frequently in JSLE patients and less frequently in LSLE patients (p < 0.05, p = 0.005) and decreased complement levels (C3, C4, and CH50) were more common in JSLE patients and less common in LSLE patients (p < 0.001, p < 0.001, and p < 0.05, respectively).

Conclusion: Our results showed that SLE patients present with different clinical and serological manifestations according to age at disease onset. JSLE patients have severe disease activity and more frequent renal involvement and LSLE patients have mild disease activity, more commonly accompanied by Sjögren’s syndrome, at disease onset.


Disclosure:

D. J. Park,
None;

J. H. Kang,
None;

K. E. Lee,
None;

J. W. Lee,
None;

L. Wen,
None;

T. J. Kim,
None;

Y. W. Park,
None;

S. S. Lee,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-clinical-and-serological-manifestations-among-juvenile-adult-and-late-onset-systemic-lupus-erythematosus-patients-in-korea/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology